We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4(+) T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.
Originele taal-2Engels
TijdschriftAntiviral Therapy
Volume17
Nummer van het tijdschrift6
Pagina's (van-tot)1097-1100
Aantal pagina's4
ISSN1359-6535
DOI's
StatusGepubliceerd - 2012

ID: 267550